INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 180 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q4 2020. The put-call ratio across all filers is 1.51 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $1,909,000 | +181.6% | 46,055 | +722.4% | 0.05% | +500.0% |
| Q2 2017 | $678,000 | -32.7% | 5,600 | -8.6% | 0.01% | -38.5% |
| Q3 2016 | $1,008,000 | -15.9% | 6,124 | +44.1% | 0.01% | -61.8% |
| Q1 2015 | $1,198,000 | +327.9% | 4,249 | +259.2% | 0.03% | +161.5% |
| Q3 2014 | $280,000 | -91.7% | 1,183 | -91.7% | 0.01% | -90.6% |
| Q2 2014 | $3,362,000 | +918.8% | 14,204 | +1320.4% | 0.14% | +557.1% |
| Q1 2014 | $330,000 | – | 1,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chicago Capital Management, LLC | 185,781 | $4,611,565 | 12.16% |
| Samsara BioCapital, LLC | 640,688 | $11,878,356 | 3.64% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 2,203,295 | $40,849,089 | 2.14% |
| Versor Investments LP | 378,480 | $7,017,019 | 1.42% |
| Magnetar Financial LLC | 2,407,209 | $44,629,655 | 1.14% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,077,893 | $38,524,136 | 0.85% |
| Fort Baker Capital Management LP | 430,600 | $7,983,324 | 0.74% |
| EHP Funds Inc. | 84,210 | $1,561,253 | 0.73% |
| Terrapin Asset Management, LLC | 30,000 | $556,200 | 0.63% |
| AQR Arbitrage LLC | 734,970 | $13,626,344 | 0.61% |